"Odds Ratio" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ratio of two odds. The exposure-odds ratio for case control data is the ratio of the odds in favor of exposure among cases to the odds in favor of exposure among noncases. The disease-odds ratio for a cohort or cross section is the ratio of the odds in favor of disease among the exposed to the odds in favor of disease among the unexposed. The prevalence-odds ratio refers to an odds ratio derived cross-sectionally from studies of prevalent cases.
| Descriptor ID |
D016017
|
| MeSH Number(s) |
E05.318.740.600.600 G17.680.500 N05.715.360.750.625.590 N06.850.520.830.600.600
|
| Concept/Terms |
Odds Ratio- Odds Ratio
- Odds Ratios
- Cross-Product Ratio
- Cross Product Ratio
- Cross-Product Ratios
- Ratio, Cross-Product
- Ratios, Cross-Product
- Relative Odds
- Odds, Relative
- Risk Ratio
- Ratio, Risk
- Ratios, Risk
- Risk Ratios
|
Below are MeSH descriptors whose meaning is more general than "Odds Ratio".
Below are MeSH descriptors whose meaning is more specific than "Odds Ratio".
This graph shows the total number of publications written about "Odds Ratio" by people in this website by year, and whether "Odds Ratio" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 3 | 3 |
| 2017 | 0 | 6 | 6 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 4 | 4 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Odds Ratio" by people in Profiles.
-
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. N Engl J Med. 2021 02 04; 384(5):428-439.
-
Impact of genetic polymorphisms in kinetochore and spindle assembly genes on chromosomal aberration frequency in healthy humans. Mutat Res Genet Toxicol Environ Mutagen. 2020 Oct - Dec; 858-860:503253.
-
Distinct pathways associated with chromosomal aberration frequency in a cohort exposed to genotoxic compounds compared to general population. Mutagenesis. 2019 12 19; 34(4):323-330.
-
HE4 as a biomarker for diagnosis of lung cancer: A meta-analysis. Medicine (Baltimore). 2019 Sep; 98(39):e17198.
-
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast Cancer Res. 2019 04 29; 21(1):55.
-
Mendelian randomization provides support for obesity as a risk factor for meningioma. Sci Rep. 2019 01 22; 9(1):309.
-
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis. Gut. 2019 06; 68(6):1099-1107.
-
Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Cancer Med. 2018 04; 7(4):1349-1358.
-
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017 09; 49(9):1373-1384.
-
Genomewide association study on monoclonal gammopathy of unknown significance (MGUS). Eur J Haematol. 2017 Jul; 99(1):70-79.
MeSH information
